These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33503424)

  • 1. Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma.
    Rathore R; Caldwell KE; Schutt C; Brashears CB; Prudner BC; Ehrhardt WR; Leung CH; Lin H; Daw NC; Beird HC; Giles A; Wang WL; Lazar AJ; Chrisinger JSA; Livingston JA; Van Tine BA
    Cell Rep; 2021 Jan; 34(4):108678. PubMed ID: 33503424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine synthesis pathway enzyme PHGDH is critical for muscle cell biomass, anabolic metabolism, and mTORC1 signaling.
    Mäntyselkä S; Kolari K; Baumert P; Ylä-Outinen L; Kuikka L; Lahtonen S; Permi P; Wackerhage H; Kalenius E; Kivelä R; Hulmi JJ
    Am J Physiol Endocrinol Metab; 2024 Jan; 326(1):E73-E91. PubMed ID: 37991454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting one-carbon metabolism requires mTOR inhibition: a new therapeutic approach in osteosarcoma.
    Rathore R; Van Tine B
    Mol Cell Oncol; 2021 Mar; 8(3):1902250. PubMed ID: 34027041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling.
    Cai Z; Li W; Hager S; Wilson JL; Afjehi-Sadat L; Heiss EH; Weichhart T; Heffeter P; Weckwerth W
    Cell Mol Immunol; 2024 May; 21(5):448-465. PubMed ID: 38409249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse Data-Driven Modeling and Multiomics Analysis Reveals Phgdh as a Metabolic Checkpoint of Macrophage Polarization and Proliferation.
    Wilson JL; Nägele T; Linke M; Demel F; Fritsch SD; Mayr HK; Cai Z; Katholnig K; Sun X; Fragner L; Miller A; Haschemi A; Popa A; Bergthaler A; Hengstschläger M; Weichhart T; Weckwerth W
    Cell Rep; 2020 Feb; 30(5):1542-1552.e7. PubMed ID: 32023468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 Inhibition.
    Rinaldi G; Pranzini E; Van Elsen J; Broekaert D; Funk CM; Planque M; Doglioni G; Altea-Manzano P; Rossi M; Geldhof V; Teoh ST; Ross C; Hunter KW; Lunt SY; Grünewald TGP; Fendt SM
    Mol Cell; 2021 Jan; 81(2):386-397.e7. PubMed ID: 33340488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism of mTORC1-mediated serine/glycine metabolism in osteosarcoma development.
    Wang DW; Wu L; Cao Y; Yang L; Liu W; E XQ; Ji G; Bi ZG
    Cell Signal; 2017 Jan; 29():107-114. PubMed ID: 27297361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine and branched-chain amino acid metabolism contribute to the growth of bone sarcomas by regulating AMPK and mTORC1 signaling.
    Martin SB; Reiche WS; Fifelski NA; Schultz AJ; Stanford SJ; Martin AA; Nack DL; Radlwimmer B; Boyer MP; Ananieva EA
    Biochem J; 2020 May; 477(9):1579-1599. PubMed ID: 32297642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NAD
    Murphy JP; Giacomantonio MA; Paulo JA; Everley RA; Kennedy BE; Pathak GP; Clements DR; Kim Y; Dai C; Sharif T; Gygi SP; Gujar S
    Cell Rep; 2018 Aug; 24(9):2381-2391.e5. PubMed ID: 30157431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.
    Li M; Wu C; Yang Y; Zheng M; Yu S; Wang J; Chen L; Li H
    Cell Oncol (Dordr); 2021 Jun; 44(3):541-556. PubMed ID: 33735398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
    Ma X; Li B; Liu J; Fu Y; Luo Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor.
    Davaadelger B; Duan L; Perez RE; Gitelis S; Maki CG
    Oncotarget; 2016 May; 7(19):27511-26. PubMed ID: 27050276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth.
    Issaq SH; Mendoza A; Kidner R; Rosales TI; Duveau DY; Heske CM; Rohde JM; Boxer MB; Thomas CJ; DeBerardinis RJ; Helman LJ
    Mol Cancer Ther; 2020 Jul; 19(7):1520-1529. PubMed ID: 32371575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics Analysis of the Role of PHGDH in Colon Cancer.
    Dai Z; Chen L; Pan K; Zhao X; Xu W; Du J; Xing C
    Technol Cancer Res Treat; 2023; 22():15330338221145994. PubMed ID: 36707056
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma.
    Arlt B; Zasada C; Baum K; Wuenschel J; Mastrobuoni G; Lodrini M; Astrahantseff K; Winkler A; Schulte JH; Finkler S; Forbes M; Hundsdoerfer P; Guergen D; Hoffmann J; Wolf J; Eggert A; Kempa S; Deubzer HE
    Int J Cancer; 2021 Mar; 148(5):1219-1232. PubMed ID: 33284994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells.
    Mullarky E; Xu J; Robin AD; Huggins DJ; Jennings A; Noguchi N; Olland A; Lakshminarasimhan D; Miller M; Tomita D; Michino M; Su T; Zhang G; Stamford AW; Meinke PT; Kargman S; Cantley LC
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2503-2510. PubMed ID: 31327531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menin regulates the serine biosynthetic pathway in Ewing sarcoma.
    Svoboda LK; Teh SSK; Sud S; Kerk S; Zebolsky A; Treichel S; Thomas D; Halbrook CJ; Lee HJ; Kremer D; Zhang L; Klossowski S; Bankhead AR; Magnuson B; Ljungman M; Cierpicki T; Grembecka J; Lyssiotis CA; Lawlor ER
    J Pathol; 2018 Jul; 245(3):324-336. PubMed ID: 29672864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.
    Mullarky E; Lucki NC; Beheshti Zavareh R; Anglin JL; Gomes AP; Nicolay BN; Wong JC; Christen S; Takahashi H; Singh PK; Blenis J; Warren JD; Fendt SM; Asara JM; DeNicola GM; Lyssiotis CA; Lairson LL; Cantley LC
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1778-83. PubMed ID: 26831078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-osteosarcoma cell activity by a mTORC1/2 dual inhibitor RES-529.
    Hu X; Wang Z; Chen M; Chen X; Liang W
    Biochem Biophys Res Commun; 2018 Mar; 497(2):499-505. PubMed ID: 29432734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells.
    Sharif T; Martell E; Dai C; Ghassemi-Rad MS; Lee K; Singh SK; Weaver ICG; Gujar S
    Cell Death Dis; 2018 Sep; 9(10):990. PubMed ID: 30250195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.